Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction

American Journal of Respiratory and Critical Care Medicine

Volumn 180, Issue 10, 2009, Pages 1010-1015

  Christie, Jason D ^a   Shah, Chirag V ^a   Kawut, Steven M ^a   Mangalmurti, Nilam ^a   Lederer, David J ^b   Sonett, Joshua R ^b   Ahya, Vivek N ^a   Palmer, Scott M ^c   Wille, Keith ^d   Lama, Vibha ^e   Shah, Pali D ^f   Shah, Ashish ^f   Weinacker, Ann ^g   Deutschman, Clifford S ^a   Kohl, Benjamin A ^a   Demissie, Ejigayehu ^a   Bellamy, Scarlett ^a   Ware, Lorraine B ^h  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d University of Alabama at Birmingham   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g STANFORD UNIVERSITY   (United States)

^h VANDERBILT UNIVERSITY   (United States)

Author keywords

Acute lung injury; Lung transplantation; Primary graft dysfunction; Receptor for advanced glycation end products; Reperfusion injury

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR;

ADULT; ALLOTRANSPLANTATION; ARTERIAL OXYGEN TENSION; ARTICLE; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; GRAFT DYSFUNCTION; GRAFT RECIPIENT; HEART VENTRICLE PRESSURE; HUMAN; INTRAOPERATIVE PERIOD; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REPERFUSION; TREATMENT OUTCOME;

ADULT; BIOLOGICAL MARKERS; BLOOD COMPONENT TRANSFUSION; COHORT STUDIES; FEMALE; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PRIMARY GRAFT DYSFUNCTION; PROSPECTIVE STUDIES; RECEPTORS, IMMUNOLOGIC; TIME FACTORS;

EID: 72849136789     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200901-0118OC     Document Type: Article

References (41)

1. Christie JD, Bavaria JE, Palevsky HI, Litzky L, Blumenthal N, Kaiser LR, Kotloff RM. Primary graft failure following lung transplantation. Chest 1998;114:51-60. (Pubitemid 28337361)
2. King RC, Binns OA, Rodriguez F, Kanithanon RC, Daniel TM, Spotnitz WD, Tribble CG, Kron IL. Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thorac Surg 2000;69:1681-1685. (Pubitemid 30445505)
3. Christie JD, Kotloff RM, Pochettino A, Arcasoy SM, Rosengard BR, Landis JR, Kimmel SE. Clinical risk factors for primary graft failure following lung transplantation. Chest 2003;124:1232-1241. (Pubitemid 37290031)
4. Christie JD, Van Raemdonck D, de Perrot M, Barr M, Keshavjee S, Arcasoy S, Orens J. Report of the ISHLT Working Group on primary lung graft dysfunction part I: introduction and methods. J Heart Lung Transplant 2005;24:1451-1453. (Pubitemid 41396438)
5. Christie JD, Robinson N,Ware LB, Plotnick M, De Andrade J, Lama V, Milstone A, Orens J, Weinacker A, Demissie E, et al. Association of protein C and type 1 plasminogen activator inhibitor with primary graft dysfunction. Am J Respir Crit Care Med 2007;175:69-74. (Pubitemid 46105311)
6. Arcasoy SM, Kotloff RM. Lung transplantation. N Engl J Med 1999;340: 1081-1091.
7. De Perrot M, Sekine Y, Fischer S, Waddell TK, McRae K, Liu M, Wigle DA, Keshavjee S. Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation. Am J Respir Crit Care Med 2002;165:211-215. (Pubitemid 34084460)
8. Christie JD, Sager JS, Kimmel SE, Ahya VN, Gaughan C, Blumenthal NP, Kotloff RM. Impact of primary graft failure on outcomes following lung transplantation. Chest 2005;127:161-165. (Pubitemid 41724571)
9. Arcasoy SM, Fisher A, Hachem RR, Scavuzzo M, Ware LB. Report of the ISHLT Working Group on primary lung graft dysfunction part V: predictors and outcomes. J Heart Lung Transplant 2005;24:1483-1488. (Pubitemid 41396442)
10. Christie JD, Kotloff RM, Ahya VN, Tino G, Pochettino A, Gaughan C, DeMissie E, Kimmel SE. The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med 2005; 171:1312-1316. (Pubitemid 40740741)
11. Krenn K, Klepetko W, Taghavi S, Lang G, Schneider B, Aharinejad S. Recipient vascular endothelial growth factor serum levels predict primary lung graft dysfunction. Am J Transplant 2007;7:700-706. (Pubitemid 46376456)
12. de Perrot M, Liu M, Waddell TK, Keshavjee S. Ischemia-reperfusioninduced lung injury. Am J Respir Crit Care Med 2003;167:490-511.
13. Covarrubias M, Ware LB, Kawut SM, De Andrade J, Milstone A, Weinacker A, Orens J, Lama V, Wille K, Bellamy S, et al. Plasma intercellular adhesion molecule-1 and von Willebrand factor in primary graft dysfunction after lung transplantation. Am J Transplant 2007;7:2573-2578. (Pubitemid 47561623)
14. Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, Arnold B, Stern DM, Nawroth PP. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med 2005;83:876-886.
15. Fehrenbach H, Kasper M, Tschernig T, Shearman MS, Schuh D, Muller M. Receptor for advanced glycation endproducts (RAGE) exhibits highly differential cellular and subcellular localisation in rat and human lung. Cell Mol Biol 1998;44:1147-1157.
16. Uchida T, Shirasawa M, Ware LB, Kojima K, Hata Y, Makita K, Mednick G, Matthay ZA, Matthay MA. Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med 2006;173:1008-1015.
17. Calfee CS, Budev MM, Matthay MA, Church G, Brady S, Uchida T, Ishizaka A, Lara A, Ranes JL, deCamp MM, et al. Plasma receptor for advanced glycation end-products predicts duration of ICU stay and mechanical ventilation in patients after lung transplantation. J Heart Lung Transplant 2007;26:675-680. (Pubitemid 47001705)
18. Christie JD, Carby M, Bag R, Corris P, Hertz M, Weill D. Report of the ISHLT Working Group on primary lung graft dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2005;24:1454-1459. (Pubitemid 41396439)
19. Daud SA, Yusen RD, Meyers BF, Chakinala MM, Walter MJ, Aloush AA, Patterson GA, Trulock EP, Hachem RR. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2007;175:507-513.
20. Oto T, Griffiths AP, Levvey BJ, Pilcher DV, Williams TJ, Snell GI. Definitions of primary graft dysfunction after lung transplantation: differences between bilateral and single lung transplantation. J Thorac Cardiovasc Surg 2006;132:140-147.
21. Oto T, Levvey BJ, Snell GI. Potential refinements of the International Society for Heart and Lung Transplantation primary graft dysfunction grading system. J Heart Lung Transplant 2007;26:431-436. (Pubitemid 46602002)
22. Whitson BA, Nath DS, Johnson AC, Walker AR, Prekker ME, Radosevich DM, Herrington CS, Dahlberg PS. Risk factors for primary graft dysfunction after lung transplantation. J Thorac Cardiovasc Surg 2006;131:73-80. (Pubitemid 43049786)
23. Whitson BA, PrekkerME, Herrington CS, Whelan TP, Radosevich DM, Hertz MI, Dahlberg PS. Primary graft dysfunction and long-term pulmonary function after lung transplantation. J Heart Lung Transplant 2007;26:1004-1011. (Pubitemid 47494652)
24. Moldanado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol 1993;138:923-936.
25. Calfee CS,Ware LB, EisnerMD, Parsons PE, Thompson BT, Wickersham N, Matthay MA, Network NA. Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 2008;63: 1083-1089.
26. Briot R, Frank JA, Uchida T, Lee JW, Calfee CS, Matthay MA. Elevated levels of RAGE, a marker of alveolar epithelial type I cell injury, predict impaired alveolar fluid clearance in isolated perfused human lungs. Chest 2009;135:269-275.
27. Ware LB, Golden JA, Finkbeiner WE, Matthay MA. Alveolar epithelial fluid transport capacity in reperfusion lung injury after lung transplantation. Am J Respir Crit Care Med 1999;159:980-988.
28. Basta G, Lazzerini G, Massaro M, Simoncini T, Tanganelli P, Fu C, Kislinger T, Stern DM, Schmidt AM, De Caterina R. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses. Circulation 2002;105:816-822. (Pubitemid 34174921)
29. Schmidt AM, Yan SD, Wautier JL, Stern D. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 1999;84:489-497. (Pubitemid 29138585)
30. Wautier JL, Zoukourian C, Chappey O, Wautier MP, Guillausseau PJ, Cao R, Hori O, Stern D, Schmidt AM. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J Clin Invest 1996;97:238-243. (Pubitemid 26021714)
31. Chavakis T, Bierhaus A, Al-Fakhri N, Schneider D, Witte S, Linn T, Nagashima M, Morser J, Arnold B, Preissner KT, et al. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med 2003;198:1507-1515. (Pubitemid 37467165)
32. Sternberg DI, Gowda R, Mehra D, Qu W, Weinberg A, Twaddell W, Sarkar J, Wallace A, Hudson B, D'Ovidio F, et al. Blockade of receptor for advanced glycation end product attenuates pulmonary reperfusion injury in mice. J Thorac Cardiovasc Surg 2008;136:1576-1585.
33. Andrassy M, Volz HC, Igwe JC, Funke B, Eichberger SN, Kaya Z, Buss S, Autschbach F, Pleger ST, Lukic IK, et al. High-mobility group box- 1 in ischemia-reperfusion injury of the heart. Circulation 2008;117: 3216-3226.
34. Zeng S, Feirt N, Goldstein M, Guarrera J, Ippagunta N, Ekong U, Dun H, Lu Y, Qu W, Schmidt AM, et al. Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice. Hepatology 2004;39: 422-432. (Pubitemid 38222183)
35. Zhang H, Tasaka S, Shiraishi Y, Fukunaga K, Yamada W, Seki H, Ogawa Y, Miyamoto K, Nakano Y, Hasegawa N, et al. Role of soluble receptor for advanced glycation end-products on endotoxininduced lung injury. Am J Respir Crit Care Med 2008;178:356-362.
36. Gong MN, Thompson BT, Williams P, Pothier L, Boyce PD, Christiani DC. Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion. Crit Care Med 2005; 33:1191-1198. (Pubitemid 40827364)
37. Netzer G, Shah CV, Iwashyna TJ, Lanken PN, Finkel B, Fuchs B, Guo W, Christie JD. Association of RBC transfusion with mortality in patients with acute lung injury. Chest 2007;132:1116-1123. (Pubitemid 47620982)
38. Zilberberg MD, Carter C, Lefebvre P, Raut M, Vekeman F, Duh MS, Shorr AF. Red blood cell transfusions and the risk of acute respiratory distress syndrome among the critically ill: a cohort study. Crit Care 2007;11:R63. (Pubitemid 47039447)
39. Wautier JL, Schmidt AM. Protein glycation: a firm link to endothelial cell dysfunction. Circ Res 2004;95:233-238.
40. Lysenko L, Mierzchala M, Gamian A, Durek G, Kubler A, Kozlowski R, Sliwinski M. The effect of packed red blood cell storage on arachidonic acid and advanced glycation end-product formation. Arch Immunol Ther Exp (Warsz) 2006;54:357-362. (Pubitemid 44627673)
41. Chavakis T, Bierhaus A, Nawroth PP. RAGE (receptor for advanced glycation end products): a central player in the inflammatory response. Microbes Infect 2004;6:1219-1225. (Pubitemid 39370091)